OTHER · Unmapped registry intervention
TRI-MOM intervention
Find medicine records ·
Find other trials using this name
Clinical trial
The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)
NCT05951751
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedThe TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
TRI-MOM interventionOTHER
Sponsors & collaborators
Institut de Recherche pour le Developpementlead sponsor
Centre Murazcollaborator
Medical Research Councilcollaborator
Institut Pasteurcollaborator
REVS PLUS Burkina Fasocollaborator
Young Gambian Mums Fundcollaborator
National AIDS Control Program Gambiacollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05951751 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.